Vaccinex Reports 2023 Financial Results and Provides Corporate Update
April 02, 2024 08:30 ET
|
Vaccinex, Inc.
Expect Topline Data for Randomized SIGNAL-AD Study of Pepinemab for Alzheimer’s Disease in Q3 2024. $17.9 million of new financing in Q4 2023 and Q1 2024.
Antibody Discovery Market Set for Steady Growth, Anticipated to Reach US$ 13.68 Bn by 2030 with a 8.9% CAGR - Insights from Persistence Market Research
January 22, 2024 06:13 ET
|
Persistence Market Research
New York, Jan. 22, 2024 (GLOBE NEWSWIRE) -- The global antibody discovery market is expected to grow at a rate of 8.9%, reaching a value of US$13.68 billion by 2030, up from US$7.53 billion in 2023....
Antibody Discovery Market Expected to Grow at a CAGR 8.9% from 2023 to 2031 | InsightAce Analytic
December 19, 2023 03:41 ET
|
InsightAce Analytic Pvt. LTd.
Jersey City, NJ, Dec. 19, 2023 (GLOBE NEWSWIRE) -- InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Antibody discovery Market Size, Share & Trends...
Global Antibody Discovery Services Market Set to Soar Past $1.6 Billion by 2023: Aiding Pharmaceutical Efficiency Through Outsourcing
October 18, 2023 06:13 ET
|
Research and Markets
Dublin, Oct. 18, 2023 (GLOBE NEWSWIRE) -- The "Antibody Discovery Market: Focus on Services and Platforms - Distribution by Type of Service Offered, Antibody Discovery Method, Type of Antibody...
Telesis Bio to Present at Antibody Engineering and Therapeutics, Europe 2023
June 06, 2023 03:00 ET
|
Telesis Bio
SAN DIEGO, June 06, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced they will be showcasing their...
Telesis Bio to Present at Protein Engineering Summit (PEGS Boston 2023)
May 15, 2023 09:00 ET
|
Telesis Bio
SAN DIEGO, May 15, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced they will be showcasing their benchtop...
Telesis Bio Reports First Quarter 2023 Financial Results
May 11, 2023 16:05 ET
|
Telesis Bio
-- Total revenue of $6.3M in 1QFY23 -- BioXp® franchise revenue increased by 28% SAN DIEGO, May 11, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and...
Antibody Discovery Market to Reach $17.2 Billion, Globally, by 2032 at 9.6% CAGR: Allied Market Research
May 03, 2023 06:30 ET
|
Allied Market Research
Portland, OR, May 03, 2023 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, “Antibody Discovery Market by Methods (Phage Display, Hybridoma, Others), by Antibody Type...
Telesis Bio to Report First Quarter Financial Results on Thursday, May 11, 2023
April 27, 2023 16:05 ET
|
Telesis Bio
SAN DIEGO, April 27, 2023 (GLOBE NEWSWIRE) -- Telesis Bio (Nasdaq: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced that it will release its first quarter...
Telesis Bio to Present at Festival of Biologics Conference
March 16, 2023 06:00 ET
|
Telesis Bio
SAN DIEGO, March 16, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced Daniel Gibson, Ph.D., CTO and...